Description
KLOW is a multi-peptide research blend combining GHK-Cu, BPC-157, TB-500, and KPV—four highly studied peptides known for their roles in cellular repair, inflammation modulation, and tissue regeneration.
The KLOW formulation consists of:
- GHK-Cu (50mg)
- BPC-157 (10mg)
- TB-500 (10mg)
- KPV (10mg)
Individual Peptide Benefits Summary :
- GHK-Cu : Tissue regeneration, Wound healing, Collagen production, Cognitive support, Anti-cancer properties, Hair/skin improvement
- BPC-157 : Gut healing, Tendon/ligament repair, Joint recovery, Neuroprotection, Mood support, Bone healing, Growth hormone receptor upregulation
- TB-500 : Cell migration, Muscle repair, Flexibility, Cardiovascular support, Anti-microbial effects, Hair growth
- KPV : Anti-inflammatory, Gut protection, IBD support, Respiratory health, Skin conditions, Immune modulation
Dosing Protocols KLOW :Â
- Reconstitution: Add 3mL bacteriostatic water to 80mg vial
- Daily Dose: 0.1mL (10 units) subcutaneous injection
- Cycle Length: 30 consecutive days
- Rest Period: Minimum 15 days between cycles
Option A : 2,667mg (10 units) = GHK-Cu 1,667mg, BPC-157 333mcg, TB-500 333mcg, KPV 333mcg
Option B : 4,000mg (15 units) = GHK-Cu 2,500mg, BPC-157 500mcg, TB-500 500mcg, KPV 500mcg
Option C : 5,333mg (20 units) = GHK-Cu 3,333mg, BPC-157 667mcg, TB-500 667mcg, KPV 667mcg
Option D : 8,000mg (30 units) = GHK-Cu 5,000mg, BPC-157 1000mcg, TB-500 1000mcg, KPV 1000mcg
Common Mild Effects :
Most users tolerate KLOW components well, with occasional reports of:
- Mild headache or light-headedness
- Initial fatigue (first few days)
- Minor injection site irritation
